ABUS

Arbutus Biopharma Corporation (ABUS)

About Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Details

Daily high

$3.26

Daily low

$3.16

Price at open

$3.18

52 Week High

$4.72

52 Week Low

$2.21

Market cap

608.3M

Dividend yield

0.00%

Volume

3.0M

Avg. volume

913,177

P/E ratio

-7.54

Arbutus Biopharma Corporation News